chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Neck pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of neck pain (pain passed up to her neck), arthralgia (pain in her right shoulder/pain went into her joint) and headache (pain back of the head) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 3, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 10, 2021, patient experienced neck pain (pain passed up to her neck), arthralgia (pain in her right shoulder/pain went into her joint) and headache (pain back of the head). The patient treated with Advil (ibuprofen) for pain relief, at an unspecified dose and frequency. At the time of the report, neck pain (pain passed up to her neck), arthralgia (pain in her right shoulder/pain went into her joint) and headache (pain back of the head) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. No concomitant medications reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular, Pain in extremity
Clinical narrative: A sore arm; She started her period 7 or 8 days early; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (She started her period 7 or 8 days early) and PAIN IN EXTREMITY (A sore arm) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included PROPRANOLOL (PROPANOLOL [PROPRANOLOL]), LORAZEPAM (ATIVAN) and OMEPRAZOLE for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced MENSTRUATION IRREGULAR (She started her period 7 or 8 days early). On an unknown date, the patient experienced PAIN IN EXTREMITY (A sore arm). At the time of the report, MENSTRUATION IRREGULAR (She started her period 7 or 8 days early) and PAIN IN EXTREMITY (A sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported. In concomitant medications blood pressure pills was reported.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and CHILLS (chills) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced FATIGUE (fatigue) and CHILLS (chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FATIGUE (fatigue) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Blood pressure measurement, Headache, Heart rate increased, Oxygen saturation
Clinical narrative: heart rate was up to 108; blood pressure dropped to 99/57; oxygen dropped to 95; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heart rate was up to 108), BLOOD PRESSURE DECREASED (blood pressure dropped to 99/57), OXYGEN SATURATION DECREASED (oxygen dropped to 95) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced HEADACHE (headache). On 27-Mar-2021, the patient experienced HEART RATE INCREASED (heart rate was up to 108), BLOOD PRESSURE DECREASED (blood pressure dropped to 99/57) and OXYGEN SATURATION DECREASED (oxygen dropped to 95). At the time of the report, HEART RATE INCREASED (heart rate was up to 108), BLOOD PRESSURE DECREASED (blood pressure dropped to 99/57), OXYGEN SATURATION DECREASED (oxygen dropped to 95) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2021, Blood pressure measurement: 99/57 (Low) dropped. On 27-Mar-2021, Oxygen saturation: 95 (Inconclusive) dropped.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment was not provided.  This case refers to a 69-year-old female patient who experienced Heart rate increased, Blood pressure decreased, oxygen saturation decreased and headache following the administration of Covid-19 vaccine.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. The underlying concomitant medication use of Lisinopril can be a confounding factor.; Sender's Comments: This case refers to a 69-year-old female patient who experienced Heart rate increased, Blood pressure decreased, oxygen saturation decreased and headache following the administration of Covid-19 vaccine.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. The underlying concomitant medication use of Lisinopril can be a confounding factor.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased
Clinical narrative: heart rate was up to 108; blood pressure dropped to 99/57; oxygen dropped to 95; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heart rate was up to 108), BLOOD PRESSURE DECREASED (blood pressure dropped to 99/57), OXYGEN SATURATION DECREASED (oxygen dropped to 95) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced HEADACHE (headache). On 27-Mar-2021, the patient experienced HEART RATE INCREASED (heart rate was up to 108), BLOOD PRESSURE DECREASED (blood pressure dropped to 99/57) and OXYGEN SATURATION DECREASED (oxygen dropped to 95). At the time of the report, HEART RATE INCREASED (heart rate was up to 108), BLOOD PRESSURE DECREASED (blood pressure dropped to 99/57), OXYGEN SATURATION DECREASED (oxygen dropped to 95) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2021, Blood pressure measurement: 99/57 (Low) dropped. On 27-Mar-2021, Oxygen saturation: 95 (Inconclusive) dropped.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment was not provided.  This case refers to a 69-year-old female patient who experienced Heart rate increased, Blood pressure decreased, oxygen saturation decreased and headache following the administration of Covid-19 vaccine.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. The underlying concomitant medication use of Lisinopril can be a confounding factor.; Sender's Comments: This case refers to a 69-year-old female patient who experienced Heart rate increased, Blood pressure decreased, oxygen saturation decreased and headache following the administration of Covid-19 vaccine.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. The underlying concomitant medication use of Lisinopril can be a confounding factor.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Joint swelling, Night sweats, Pain in extremity, Vaccination site induration
Clinical narrative: sore arm; night sweats; knees felt like the joints inside were swelling; became difficult to walk; golf ball sized hardness on injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), NIGHT SWEATS (night sweats), JOINT SWELLING (knees felt like the joints inside were swelling), GAIT DISTURBANCE (became difficult to walk) and VACCINATION SITE INDURATION (golf ball sized hardness on injection site) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), NIGHT SWEATS (night sweats) and VACCINATION SITE INDURATION (golf ball sized hardness on injection site). an unknown date, the patient experienced JOINT SWELLING (knees felt like the joints inside were swelling) and GAIT DISTURBANCE (became difficult to walk). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), NIGHT SWEATS (night sweats), JOINT SWELLING (knees felt like the joints inside were swelling), GAIT DISTURBANCE (became difficult to walk) and VACCINATION SITE INDURATION (golf ball sized hardness on injection site) outcome was unknown. Not Provided          No concomitant medications were reported.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (pain on the injection site) and myalgia (muscle pain in the right thigh) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 031A21A) for COVID-19 immunization. No medical history reported. On Mar 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 24, 2021, patient experienced vaccination site pain (pain on the injection site). On Mar 25, 2021, patient experienced myalgia (muscle pain in the right thigh). On Mar 27, 2021, vaccination site pain (pain on the injection site) resolved. At the time of the report, myalgia (muscle pain in the right thigh) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Heart rate, Lymphadenopathy
Clinical narrative: little light headed; couldn't take deep breaths/ started having winded feeling; had swollen lymph nodes under my left arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (little light headed), DYSPNOEA (couldn't take deep breaths/ started having winded feeling) and LYMPHADENOPATHY (had swollen lymph nodes under my left arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthmatic and Allergy (allergic to everything since childhood).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (little light headed) and DYSPNOEA (couldn't take deep breaths/ started having winded feeling). an unknown date, the patient experienced LYMPHADENOPATHY (had swollen lymph nodes under my left arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (little light headed), DYSPNOEA (couldn't take deep breaths/ started having winded feeling) and LYMPHADENOPATHY (had swollen lymph nodes under my left arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: rapid (High) rapid heartbeat, Intermittent episodes came back again on and off for 4 days.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 026L20A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 20-Aug-2020 and the estimated date of delivery was 27-May-2021. On 05-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  On 05-Jan-2021, EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Sep-2020, Pregnancy test: positive (Positive) Positive.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Some of the fluids ran all the way down to her elbow; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (Some of the fluids ran all the way down to her elbow) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL UNDERDOSE (Some of the fluids ran all the way down to her elbow). On 17-Feb-2021, ACCIDENTAL UNDERDOSE (Some of the fluids ran all the way down to her elbow) had resolved. Not Provided          Relevant concomitant medications were not reported.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to -MODERNATX, INC.-MOD-2021-060914 (E2B Linked Report).; Sender's Comments:  -MODERNATX, INC.-MOD-2021-060914:1st dose case
Sex: M
Vaccine: COVID19
Symptoms: Swelling face, Swollen tongue, Taste disorder
Clinical narrative: mild swelling of the inside of the cheeks and both sides of tongue; experiences a bad taste; mild swelling of the inside of the cheeks and both sides of tongue; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (mild swelling of the inside of the cheeks and both sides of tongue), TASTE DISORDER (experiences a bad taste) and SWELLING FACE (mild swelling of the inside of the cheeks and both sides of tongue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWOLLEN TONGUE (mild swelling of the inside of the cheeks and both sides of tongue), TASTE DISORDER (experiences a bad taste) and SWELLING FACE (mild swelling of the inside of the cheeks and both sides of tongue). At the time of the report, SWOLLEN TONGUE (mild swelling of the inside of the cheeks and both sides of tongue), TASTE DISORDER (experiences a bad taste) and SWELLING FACE (mild swelling of the inside of the cheeks and both sides of tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: I was diagnosed with Covid-19; arm is sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I was diagnosed with Covid-19) and VACCINATION SITE PAIN (arm is sore at the injection site) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (She also admitted diagnosed with COVID-19 in October 2020) in October 2020.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced COVID-19 (I was diagnosed with Covid-19) and VACCINATION SITE PAIN (arm is sore at the injection site). At the time of the report, COVID-19 (I was diagnosed with Covid-19) and VACCINATION SITE PAIN (arm is sore at the injection site) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, SARS-CoV-2 test: positive (Positive) she was diagnosed with COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Outcome of event updated. Patient reported she was fine.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event (vaccination site pain), a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Hyperhidrosis, Myalgia
Clinical narrative: sweating; muscle pain on his back and wrist; sore, muscle ache, pain; joint pain/ pain on his wrist; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), BACK PAIN (muscle pain on his back and wrist), MYALGIA (sore, muscle ache, pain), ARTHRALGIA (joint pain/ pain on his wrist) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced HYPERHIDROSIS (sweating), BACK PAIN (muscle pain on his back and wrist), MYALGIA (sore, muscle ache, pain), ARTHRALGIA (joint pain/ pain on his wrist) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (sweating), BACK PAIN (muscle pain on his back and wrist), MYALGIA (sore, muscle ache, pain), ARTHRALGIA (joint pain/ pain on his wrist) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: sweating; muscle pain on his back and wrist; sore, muscle ache, pain; joint pain/ pain on his wrist; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), BACK PAIN (muscle pain on his back and wrist), MYALGIA (sore, muscle ache, pain), ARTHRALGIA (joint pain/ pain on his wrist) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced HYPERHIDROSIS (sweating), BACK PAIN (muscle pain on his back and wrist), MYALGIA (sore, muscle ache, pain), ARTHRALGIA (joint pain/ pain on his wrist) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (sweating), BACK PAIN (muscle pain on his back and wrist), MYALGIA (sore, muscle ache, pain), ARTHRALGIA (joint pain/ pain on his wrist) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Fatigue
Clinical narrative: lots of confusion; fatigue - that he is used to; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (lots of confusion) and FATIGUE (fatigue - that he is used to) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concomitant products included NAPROXEN for Product used for unknown indicaton, GABAPENTIN, DULOXETINE, CLONAZEPAM, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and ATORVASTATIN for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (lots of confusion) and FATIGUE (fatigue - that he is used to). At the time of the report, CONFUSIONAL STATE (lots of confusion) and FATIGUE (fatigue - that he is used to) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication were not reported
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Skin irritation, Skin swelling, Swelling, Vaccination site warmth
Clinical narrative: irritated; puffy; red; hot; swollen; This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (irritated), SKIN SWELLING (puffy), ERYTHEMA (red), VACCINATION SITE WARMTH (hot) and SWELLING (swollen) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced SKIN IRRITATION (irritated), SKIN SWELLING (puffy), ERYTHEMA (red), VACCINATION SITE WARMTH (hot) and SWELLING (swollen). At the time of the report, SKIN IRRITATION (irritated), SKIN SWELLING (puffy), ERYTHEMA (red), VACCINATION SITE WARMTH (hot) and SWELLING (swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash, Vaccination site erythema
Clinical narrative: Arm was sore; Rash on neck, chest, and both arms; arms were red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), RASH (Rash on neck, chest, and both arms) and VACCINATION SITE ERYTHEMA (arms were red) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 038K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore), RASH (Rash on neck, chest, and both arms) and VACCINATION SITE ERYTHEMA (arms were red). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at a dose of 1 dosage form. On 11-Mar-2021, RASH (Rash on neck, chest, and both arms) and VACCINATION SITE ERYTHEMA (arms were red) had resolved. On 12-Mar-2021, PAIN IN EXTREMITY (Arm was sore) had resolved. Not Provided          Concomitant medication information was not reported. Treatment- Ibuprofen Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow up was attached on 05 May 2021 and contains No NewInformation. On 22-Jun-2021: Follow up received on 22-JUN-2021:contains No new information
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Tetanus immunisation
Clinical narrative: Fell and cut their left leg on their calf with rusty bob-wire; Got a tetanus shot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FALL (Fell and cut their left leg on their calf with rusty bob-wire) and TETANUS IMMUNISATION (Got a tetanus shot) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included METFORMIN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced FALL (Fell and cut their left leg on their calf with rusty bob-wire) and TETANUS IMMUNISATION (Got a tetanus shot). On 22-Mar-2021, TETANUS IMMUNISATION (Got a tetanus shot) outcome was unknown. At the time of the report, FALL (Fell and cut their left leg on their calf with rusty bob-wire) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information mentioned tetanus shot, bacitracin and keeping the area clean.  Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Muscle tightness
Clinical narrative: tightness in arm; slight headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (tightness in arm), HEADACHE (slight headache) and FATIGUE (fatigue) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Insomnia and Brachial plexus injury. Concomitant products included CYCLOSPORINE for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 24-Mar-2021, the patient experienced MUSCLE TIGHTNESS (tightness in arm), HEADACHE (slight headache) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 25-Mar-2021, HEADACHE (slight headache) had resolved. On 26-Mar-2021, MUSCLE TIGHTNESS (tightness in arm) and FATIGUE (fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with the drug was not applicable.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Nasal congestion, Pain in extremity, Sinus headache
Clinical narrative: stuffy head; trouble breathing; sinus headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), NASAL CONGESTION (stuffy head), DYSPNOEA (trouble breathing) and SINUS HEADACHE (sinus headache) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 28-Mar-2021, the patient experienced NASAL CONGESTION (stuffy head), DYSPNOEA (trouble breathing) and SINUS HEADACHE (sinus headache). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 27-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved. On 28-Mar-2021, NASAL CONGESTION (stuffy head) and SINUS HEADACHE (sinus headache) had resolved and DYSPNOEA (trouble breathing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: Injection site was warm; Left arm began hurting; Injection site was red; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site was warm), VACCINATION SITE PAIN (Left arm began hurting), VACCINATION SITE ERYTHEMA (Injection site was red), CHILLS (Chills) and FATIGUE (Fatigue) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site was warm), VACCINATION SITE PAIN (Left arm began hurting), VACCINATION SITE ERYTHEMA (Injection site was red), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, VACCINATION SITE WARMTH (Injection site was warm), VACCINATION SITE PAIN (Left arm began hurting), VACCINATION SITE ERYTHEMA (Injection site was red), CHILLS (Chills) and FATIGUE (Fatigue) had resolved.            Concomitant product use was not provided by the reporter. No treatment information was provided. Action taken with mRNA-1273 in response to the events were Not Applicable   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow up document was attached on 12-May-2021 which contains updated outcome of the events as recovered.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Chills, Fatigue, Feeling cold
Clinical narrative: flu-like feeling; body feeling very weak; achy in back and legs; body is not warm, it is more cold; chills/shivering; body aches; headache; felt tired/fatigued; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), BACK PAIN (achy in back and legs), FEELING COLD (body is not warm, it is more cold), INFLUENZA LIKE ILLNESS (flu-like feeling) and ASTHENIA (body feeling very weak) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder. Concomitant products included METFORMIN HYDROCHLORIDE (METFORMIN [METFORMIN HYDROCHLORIDE]), METOPROLOL TARTRATE (METOPROLOL [METOPROLOL TARTRATE]) and LOVASTATIN for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced FATIGUE (felt tired/fatigued). On 20-Mar-2021, the patient experienced PAIN (body aches) and HEADACHE (headache). On 23-Mar-2021, the patient experienced FEELING COLD (body is not warm, it is more cold) and CHILLS (chills/shivering). On an unknown date, the patient experienced BACK PAIN (achy in back and legs), INFLUENZA LIKE ILLNESS (flu-like feeling) and ASTHENIA (body feeling very weak). The patient was treated with PARACETAMOL (TYLENOL) from 23-Mar-2021 to 28-Mar-2021 at an unspecified dose and frequency. At the time of the report, PAIN (body aches), BACK PAIN (achy in back and legs), FEELING COLD (body is not warm, it is more cold), INFLUENZA LIKE ILLNESS (flu-like feeling), ASTHENIA (body feeling very weak), CHILLS (chills/shivering), FATIGUE (felt tired/fatigued) and HEADACHE (headache) outcome was unknown.            Action taken with mRNA-1273 is not applicable
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Pain
Clinical narrative: flu-like feeling; body feeling very weak; achy in back and legs; body is not warm, it is more cold; chills/shivering; body aches; headache; felt tired/fatigued; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), BACK PAIN (achy in back and legs), FEELING COLD (body is not warm, it is more cold), INFLUENZA LIKE ILLNESS (flu-like feeling) and ASTHENIA (body feeling very weak) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder. Concomitant products included METFORMIN HYDROCHLORIDE (METFORMIN [METFORMIN HYDROCHLORIDE]), METOPROLOL TARTRATE (METOPROLOL [METOPROLOL TARTRATE]) and LOVASTATIN for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced FATIGUE (felt tired/fatigued). On 20-Mar-2021, the patient experienced PAIN (body aches) and HEADACHE (headache). On 23-Mar-2021, the patient experienced FEELING COLD (body is not warm, it is more cold) and CHILLS (chills/shivering). On an unknown date, the patient experienced BACK PAIN (achy in back and legs), INFLUENZA LIKE ILLNESS (flu-like feeling) and ASTHENIA (body feeling very weak). The patient was treated with PARACETAMOL (TYLENOL) from 23-Mar-2021 to 28-Mar-2021 at an unspecified dose and frequency. At the time of the report, PAIN (body aches), BACK PAIN (achy in back and legs), FEELING COLD (body is not warm, it is more cold), INFLUENZA LIKE ILLNESS (flu-like feeling), ASTHENIA (body feeling very weak), CHILLS (chills/shivering), FATIGUE (felt tired/fatigued) and HEADACHE (headache) outcome was unknown.            Action taken with mRNA-1273 is not applicable
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: diarrhea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and VOMITING (vomiting) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 096AZ1A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history was reported).    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced DIARRHOEA (diarrhea) and VOMITING (vomiting). At the time of the report, DIARRHOEA (diarrhea) and VOMITING (vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment details was not provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: injection site turned red after couple of days; 2 inch wide and 4 to 5 inch in length patch from the top of the muscle down to the injection site; shot getting itchy; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PRURITUS (shot getting itchy), VACCINATION SITE ERYTHEMA (injection site turned red after couple of days) and SKIN DISCOLOURATION (2 inch wide and 4 to 5 inch in length patch from the top of the muscle down to the injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030AZIA) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (shot getting itchy). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (injection site turned red after couple of days) and SKIN DISCOLOURATION (2 inch wide and 4 to 5 inch in length patch from the top of the muscle down to the injection site). At the time of the report, VACCINATION SITE PRURITUS (shot getting itchy), VACCINATION SITE ERYTHEMA (injection site turned red after couple of days) and SKIN DISCOLOURATION (2 inch wide and 4 to 5 inch in length patch from the top of the muscle down to the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment medications were provided
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Malaise
Clinical narrative: chills; felt bad; going to be sick to her stomach; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MALAISE (felt bad) and ABDOMINAL DISCOMFORT (going to be sick to her stomach) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016b21a and 025a2119) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included lisinpril, METOPROLOL, meloxigan and ATORVASTATIN CALCIUM (ATORVASTIN) for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced CHILLS (chills), MALAISE (felt bad) and ABDOMINAL DISCOMFORT (going to be sick to her stomach). At the time of the report, CHILLS (chills), MALAISE (felt bad) and ABDOMINAL DISCOMFORT (going to be sick to her stomach) outcome was unknown.            No treatment medications were provided
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received the vaccine after the 6 hour vial puncture expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received the vaccine after the 6 hour vial puncture expiry) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received the vaccine after the 6 hour vial puncture expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received the vaccine after the 6 hour vial puncture expiry) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: This report refers to a case of Expired product administered for mRNA-1273, lot # 012M20A, with no associated AEs.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site discolouration, Vaccination site pain
Clinical narrative: bruising; His arm was black and blue from shoulder to elbows".; severe arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (bruising), VACCINATION SITE DISCOLOURATION (His arm was black and blue from shoulder to elbows".) and VACCINATION SITE PAIN (severe arm pain) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE BRUISING (bruising), VACCINATION SITE DISCOLOURATION (His arm was black and blue from shoulder to elbows".) and VACCINATION SITE PAIN (severe arm pain). At the time of the report, VACCINATION SITE BRUISING (bruising), VACCINATION SITE DISCOLOURATION (His arm was black and blue from shoulder to elbows".) and VACCINATION SITE PAIN (severe arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided No concomitant medications were provided Action taken with mRNA-1273 is unknown   This case was linked to US-MODERNATX, INC.-MOD-2021-060528 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060528:MOD-2021-060528 (Wife case)
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Heart rate abnormal, Pain
Clinical narrative: little soreness; heart rate started to go up and down, fluctuating; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (little soreness) and HEART RATE ABNORMAL (heart rate started to go up and down, fluctuating) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included MELOXICAM for Arthritis, MONTELUKAST SODIUM for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced HEART RATE ABNORMAL (heart rate started to go up and down, fluctuating). On an unknown date, the patient experienced PAIN (little soreness). On 09-Mar-2021, HEART RATE ABNORMAL (heart rate started to go up and down, fluctuating) had resolved. At the time of the report, PAIN (little soreness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 118 /min (High) Heart rate was high., 120 /min (High) Heart rate was high, 85 /min (normal) Heart rate was normal, 125 /min (High) Heart rate was high, 140 /min (High) Heart rate was high, 90 /min (normal) Heart rate was normal. and 177 /min (High) Heart rate was high..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Surgery
Clinical narrative: gum surgery; This spontaneous case was reported by a consumer and describes the occurrence of SURGERY (gum surgery) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CERIVASTATIN and CELECOXIB (CELEXA [CELECOXIB]) for an unknown indication.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SURGERY (gum surgery). The patient was treated with AMOXICILLIN ongoing since an unknown date for Surgery, at an unspecified dose and frequency. At the time of the report, SURGERY (gum surgery) outcome was unknown. Amoxicillin          Action taken with mRNA-1273 is not applicable
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment medication provided. no concomitant medication provided. The patient gave consent for safety team to contact him but not his health care provider. Patient was unable to provide information on lot and expiration date. The patient showed concerned about getting the second dose of Moderna COVID-19 vaccine second dose was scheduled on 04Apr2021.